Skip to Main Content

Paper Details

Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.
Eur J Cancer
8
2022
Author NameAffiliation
Anthony M JoshuaKinghorn Cancer Centre, St. Vincent's Hospital
Howard I ScherMemorial Sloan Kettering Cancer Center
Johann S de BonoThe Institute of Cancer Research and the Royal Marsden NHS Foundation Trust
Maha HussainRobert H. Lurie Comprehensive Cancer Center, Northwestern University
Cora N SternbergEnglander Institute for Precision Medicine, Meyer Cancer Center
Tomasz M BeerOHSU Knight Cancer Institute, Oregon Health & Science University
  • 1 - 6

Datasets